Tae Sung
Impact in
-
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
-
- Calcium signaling and nucleotide metabolism
Papers in
- Oncology 8
- Neutropenia and Cancer Infections 3
- Lung Cancer Research Studies 3
- Cancer Treatment and Pharmacology 2
- Cancer-related Molecular Pathways 2
-
- Advanced Breast Cancer Therapies 4
- Co-authors
- Bart Jessen (5 shared papers)Wenyue Hu (8 shared papers)Shuyan Lu (3 shared papers)Nianwei Lin (1 shared paper)Robert T. Abraham (1 shared paper)Aida Sacaan (3 shared papers)Stéphane Thibault (2 shared papers)Martin B. Finkelstein (3 shared papers)
- Journals
- Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)Toxicological Sciences (1 paper)CPT Pharmacometrics & Systems Pharmacology (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesSouth KoreaFrance
In The Last Decade
Tae Sung
11 papers receiving 304 citations
Peers
Comparison fields: 5 of 71
- Oncology 145
- Physiology 22
- Genetics 44
- Pulmonary and Respiratory Medicine 130
- Cancer Research 34
Countries citing papers authored by Tae Sung
This map shows the geographic impact of Tae Sung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tae Sung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tae Sung more than expected).
Fields of papers citing papers by Tae Sung
This network shows the impact of papers produced by Tae Sung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tae Sung. The network helps show where Tae Sung may publish in the future.
Co-authors
The 25 scholars most cited alongside Tae Sung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 132 | |
| 2 | 2017 | 109 | |
| 3 | 2018 | 23 | |
| 4 | 2020 | 11 | |
| 5 | 2019 | 11 | |
| 6 | 2020 | 6 | |
| 7 | 2020 | 5 | |
| 8 | 2015 | 3 | |
| 9 | 2021 | 2 | |
| 10 | 2022 | 2 | |
| 11 | 2002 | 1 |
About Tae Sung
Tae Sung is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Epidemiology and Molecular Biology, having authored 11 papers that have together received 305 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (4 papers), Blood disorders and treatments (3 papers), Neutropenia and Cancer Infections (3 papers), Lung Cancer Research Studies (3 papers), Cancer Treatment and Pharmacology (2 papers), Cancer-related Molecular Pathways (2 papers), Phytochemistry and Biological Activities (1 paper) and Lysosomal Storage Disorders Research (1 paper). The work is most often cited by research in Oncology (145 citations), Physiology (22 citations), Genetics (44 citations), Pulmonary and Respiratory Medicine (130 citations) and Cancer Research (34 citations). Tae Sung has collaborated with scholars based in United States, South Korea and France. Frequent co-authors include Bart Jessen, Wenyue Hu, Shuyan Lu, Nianwei Lin, Robert T. Abraham, Aida Sacaan, Stéphane Thibault, Martin B. Finkelstein, Nasir Khan and David Z. D’Argenio. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Toxicological Sciences, CPT Pharmacometrics & Systems Pharmacology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.